Form 4: Arcus Biosciences CEO Terry Rosen Sells Shares to Cover Tax Obligations and Adjusts Holdings Due to Domestic Relations Order
SEC Form 4 Filing
Arcus Biosciences CEO Terry Rosen sold 37,882 shares to cover tax obligations and adjusted his holdings by 1,547,062 shares due to a domestic relations order.
Summary
- Arcus Biosciences CEO Terry Rosen sold 37,882 shares of common stock on December 15, 2024, at a price of $16.08 per share.
- This sale was a 'net settlement' by the company to cover tax withholding obligations related to the vesting of previously granted Restricted Stock Units (RSUs).
- Additionally, Mr. Rosen's beneficial ownership of Arcus Biosciences stock decreased by 1,547,062 shares due to a domestic relations order.
- Following these transactions, Mr. Rosen beneficially owns 2,369,360 shares of Arcus Biosciences common stock.
Sentiment
Score: 5
Explanation: The document reflects standard insider trading activity with a neutral impact. The tax-related sale is expected, and the domestic relations order is a personal matter not directly related to the company's performance.
Risks
- The sale of shares by the CEO, even for tax purposes, could be perceived negatively by some investors.
- The significant reduction in share ownership due to a domestic relations order might raise questions about the CEO's personal circumstances.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders who trade company stock. The transactions are not unusual, but the domestic relations order is a less common event.
Comparison to Industry Standards
- Form 4 filings are a standard practice for all publicly traded companies in the US, and the transactions reported here are typical for executives who receive stock-based compensation.
- The sale of shares to cover tax obligations is a common occurrence when RSUs vest.
- The reduction in share ownership due to a domestic relations order is not a standard event and is specific to the individual circumstances of the executive.
Stakeholder Impact
- The share sale may have a minor negative impact on shareholder sentiment, but it is a common practice for executives.
- The reduction in share ownership due to a domestic relations order is unlikely to have a significant impact on stakeholders.
Key Dates
| Date | Description |
|---|---|
| 12/15/2024 | Date of the share sale transaction and change in beneficial ownership. |
| 12/17/2024 | Date the Form 4 was signed by the Attorney-in-Fact. |
Keywords
Arcus Biosciences, Terry Rosen, CEO, share sale, Form 4, insider trading, domestic relations order, tax obligations, RSUs, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.